Plus, news about Gilead Sciences and Yuhan:
Vanda gets second unsolicited offer: Cycle Group Holdings again submitted a proposal to buy Vanda for
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Researchers highlight the unprecedented success of GLP-1-based multi-receptor drugs in achieving substantial weight loss and improved health outcomes, potentially replacing bariatric surgery for obesity treatment.
There’s no doubt about the biggest story in tech over the last year: the rapid rise of generative AI. Although the underlying technology that powers
In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social